Rx Drug News

Complete Archives

2013 May
- EU watchdog backs Bayer acne drug for certain patients
- Newer whooping cough vaccine not as protective
- Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak
- Promising Alzheimer’s drug Gammagard fails key study
- FDA OKs Liptruzet for High LDL
- FDA’s Deborah Autor to join drugmaker Mylan
- FDA approves Plan B for girls as young as 15
2013 April
- FDA rejects two Gilead HIV drugs as standalone products
- Merck, Pfizer to jointly develop diabetes drug
- Pfizer�s Arthritis Drug Rejected by European Regulators
- Latest HIV vaccine doesn’t work; govt halts study
- FDA to launch tool to detect fake, substandard malaria drugs
- Sanofi infant vaccine gets EU approval
- FDA Updates OxyContin Label, Blocks Generics
- FDA advisory panel to reconsider Avandia safety
- Heart Drug Linked to Cancer
- 2-Drug Combo More Effective in Treating Sarcomas, Moffitt Cancer Center Study Shows
- Roche to use Isis’s technology to develop brain disorder drug
- FDA OK’s first drug for morning sickness in more than 50 years
- Lundbeck antidepressant gets boost from clinical trial
- Antibody evolution could guide HIV vaccine development
- Court upholds $142 million verdict against Pfizer over Neurontin
- After long fight, Roche to release all Tamiflu drug data
- Merrimack lung cancer drug fails in one mid-stage trial group
- Can Meditation Make You a More Compassionate Person?
2013 March
- Biogen prices new MS drug at discount to key competitors
- Georgia compounding pharmacy recalls sterile products: FDA
- Harnessing immune cells’ adaptability to design an effective HIV vaccine
- AstraZeneca to axe 1,600 jobs in overhaul of drug R&D
- Novo Nordisk obesity drug results underwhelm investors
- Novartis says Alcon’s eye drug Jetrea gets EU approval
- EU expands use of Roche’s Pegasys in chronic hepatitis C
- FDA warns Stryker on quality issues, marketing practices
- Merck Vytorin study to continue after panel review
2013 February
- FDA halts trials of Amgen drug in children, cites death
- GlaxoSmithKline unit joins patent pool for AIDS drugs
- FDA halts trials of Amgen drug in children, cites death
- FDA approves Roche drug for late-stage breast cancer
- Queen’s study shows psychotropic drug dispensing increases on entry to care homes
- FDA approves new silicone breast implant from Allergan
- New drug combination could prevent head and neck cancer in high-risk patients
- New study on Hepatitis C drug treatment in vivo and in vitro
- Novo to sell Tresiba in Europe at 60-70 percent premium over Lantus
- GSK wins priority status for new HIV drug in U.S
- FDA approves first retinal implant for rare eye disease
- GSK wins priority status for new HIV drug in U.S
- Court grants Indiana employer relief from contraceptives mandate
- Drugmakers eye Africa’s middle classes as next growth market
- Elan seeks acquisitions after $3.25 billion MS drug deal
- Europe faces cost cuts as GSK promises return to growth
- Biogen’s purchase of MS drug ends rocky partnership with Elan
- Study finds potential to match tumors with known cancer drugs
- Tuberculosis vaccine hopes dashed
- Gilead’s two hepatitis C drug trials meet study goals
- Hemispherx says FDA rejects fatigue drug application
- Tracking the evolution of antibiotic resistance
2013 January
- UNC scientists unveil a superbug�s secret to antibiotic resistance
- Erectile dysfunction drug also helps men ejaculate and orgasm
- New Drug Improves Survival in Multiple Myeloma Relapse, Moffitt Cancer Center Researchers Say
- Lilly stomach cancer drug extends survival vs placebo
- J&J mulls sale of diagnostics unit
- Novartis expects sales to grow from 2014
- Creditors probe meningitis-linked pharmacy owners’ pay
- Exposure to COI policies during residency reduces rate of brand antidepressant prescriptions
- AstraZeneca’s new CEO removes R&D, commercial heads
- Tamoxifen ameliorates symptoms of Duchenne muscular dystrophy
- Patients rarely told about medication errors: study
- Scientists find a new way to boost common cancer drugs
- France will ask EU to curb use of newer birth control pills
- Alzheimer’s Drug Dials Back Deafness In Mice
- New U.S. food safety rules by FDA seek more accountability
- New method for uncovering side effects before a drug hits the market
- U.S. approves J&J drug-resistant tuberculosis treatment
2012 December
- Keep thimerosal in vaccines: pediatricians
- Keep thimerosal in vaccines: pediatricians
- Bayer seeks U.S. FDA approval for radium-223
- FDA OKs Expanded Use of Prostate Cancer Drug
- India revokes patent on Merck & Co asthma drug
- More than a third of high-risk leukemia patients respond to an experimental new drug
- New drug cuts risk of deadly transplant side effect in half
- Baxter to buy Sweden’s Gambro for $4 billion
- GSK hopes for 14 new drug successes in 2013-14
- Cell surface transporters exploited for cancer drug delivery
- Ranbaxy products in Malaysia safe to consume
2012 November
- J&J says it won’t enforce AIDS drug patent in Africa
- India’s Ranbaxy launches acne drug in US
- Drug industry resists more oversight despite meningitis outbreak
- Novartis drug helps patients with rare inflammatory diseases
- ADHD medicine affects the brain�s reward system
- Vertex posts loss as hepatitis drug sales plunge
2012 October
- Bayer says to acquire U.S. vitamin maker Schiff
- A Viagra follow-up? Drug used to treat glaucoma actually grows human hair
- Novartis third-quarter sales miss expectations
- Experts call for increased neonatal inclusion in pediatric drug trials
- GlaxoSmithKline says five late-stage trials meet main goal
- Lilly’s dulaglutide tops 3 diabetes drugs in late-stage trials
- Meningitis toll rises; pharmacy owners sued
- Compounding pharmacies need FDA oversight
- Actelion keeps growth outlook after third quarter beat
- The meds stop working so WebMD needs a makeover

Subscribe to the "News" RSS Feed

TOP ۞

EU watchdog backs Bayer acne…
Bayer’s acne pill Diane 35 and its generic versions are…
Newer whooping cough vaccine not…
A newer version of the whooping cough vaccine doesn’t protect…
Whole-cell vaccine was more effective…
Whole-cell pertussis vaccines were more effective at protecting against pertussis…
Promising Alzheimer’s drug Gammagard fails…
An experimental Alzheimer’s drug that showed promise a year ago…
FDA OKs Liptruzet for High…
The FDA approved Liptruzet, a combination of ezetimibe and atorvastatin,…
FDA’s Deborah Autor to join…
Generic drugmaker Mylan Inc said on Tuesday it hired…
FDA approves Plan B for…
The U.S. Food and Drug Administration on Tuesday said it…
FDA rejects two Gilead HIV…
Gilead Sciences Inc said on Monday that U.S. health rejected…
Merck, Pfizer to jointly develop…
Drugmakers Pfizer Inc and Merck & Co Inc said they…
Pfizer�s Arthritis Drug Rejected by…
Pfizer Inc. (PFE)�s rheumatoid arthritis pill failed to win the…

About Us | Privacy Policy | Terms of Use | Contact Us

© 2012 RxDrug News 1999-2012. All rights reserved